GlassScriptPhysician profile
Brian W Peterson
NPI 1639330996
$8,581.45
in general payments reported to CMS, 2019-2025
53 companies · $2,301 in 2025
The $2,301 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $371 · 2021: $926 · 2022: $1,249 · 2023: $1,265 · 2024: $2,249 · 2025: $2,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,814.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,449.15 | 2021-2025 | |
| Ucb, INC. | $688.33 | 2019-2025 | Briviact, Fintepla, Zilbrysq |
| Argenx US, INC. | $537.12 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Novartis Pharmaceuticals Corporation | $442.34 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $424.64 | 2019-2025 | Nuplazid |
| Lilly USA, LLC | $414.19 | 2020-2025 | Amyvid, Kisunla, Emgality |
| Biogen, INC. | $313.89 | 2021-2025 | Tysabri, Vumerity, Skyclarys |
| Eisai INC. | $313.39 | 2021-2025 | |
| Grifols USA, LLC | $279.15 | 2019-2025 | Gamunex-C |
| Pfizer INC. | $273.90 | 2023-2025 | |
| Neurelis, INC. | $269.73 | 2021-2025 | Valtoco |
| Lundbeck LLC | $245.17 | 2019-2025 | Vyepti, Rexulti |
| Amneal Pharmaceuticals LLC | $241.43 | 2024 | Ongentys, Rytary |
| Amgen INC. | $208.60 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $203.15 | 2022-2025 | Ultomiris, Soliris |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.